Proton NMR-Based Metabolite Analyses of Archived Serial Paired Serum and Urine Samples from Myeloma Patients at Different Stages of Disease Activity Identifies Acetylcarnitine as a Novel Marker of Active Disease

BACKGROUND: Biomarker identification is becoming increasingly important for the development of personalized or stratified therapies. Metabolomics yields biomarkers indicative of phenotype that can be used to characterize transitions between health and disease, disease progression and therapeutic res...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodi, Alessia, Tiziani, Stefano, Khanim, Farhat L., Günther, Ulrich L., Viant, Mark R., Morgan, Gareth J., Bunce, Christopher M., Drayson, Mark T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576408/
https://www.ncbi.nlm.nih.gov/pubmed/23431376
http://dx.doi.org/10.1371/journal.pone.0056422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576408/
https://www.ncbi.nlm.nih.gov/pubmed/23431376
http://dx.doi.org/10.1371/journal.pone.0056422

Ejemplares similares